<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36233516</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Post-COVID Pain Is Not Associated with Inflammatory Polymorphisms in People Who Had Been Hospitalized by COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5645</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11195645</ELocationID><Abstract><AbstractText>Our aim was to assess the association between four inflammatory polymorphisms with the development of post-COVID pain and to associate these polymorphisms with the clinical pain phenotype in individuals who had been hospitalized by COVID-19. Three potential genotypes of IL-6 (rs1800796), IL-10 (rs1800896), TNF-&#x3b1; (rs1800629), and IFITM3 (rs12252) single nucleotide polymorphisms (SNPs) were obtained from no-stimulated saliva samples from 293 (49.5% female, mean age: 55.6 &#xb1; 12.9 years) previously hospitalized COVID-19 survivors by polymerase chain reactions. Pain phenotyping consisted of the evaluation of pain features, sensitization-associated symptoms, anxiety levels, depressive levels, sleep quality, catastrophizing, and kinesiophobia levels in patients with post-COVID pain. Analyses were conducted to associate clinical features with genotypes. One hundred and seventeen (39.9%) patients experienced post-COVID pain 17.8 &#xb1; 5.2 months after hospital discharge. No significant differences in the distribution of the genotype variants of any SNPs were identified between COVID-19 survivors with and without post-COVID pain (all, p &gt; 0.47). Similarly, the clinical pain phenotype was not significantly different between patients with and without post-COVID pain since no differences in any variable were observed for any SNPs. In conclusion, four SNPs associated with inflammatory and immune responses did not appear to be associated with post-COVID pain in previously hospitalized COVID-19 survivors. Further, neither of the SNPs were involved in the phenotyping features of post-COVID pain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, School of Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1331-129X</Identifier><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, School of Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Gil</LastName><ForeName>Gema</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Research group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Esquer</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5426-4349</Identifier><AffiliationInfo><Affiliation>Research group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambite-Quesada</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6755-8189</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palomar-Gallego</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Research group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0892-1579</Identifier><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, School of Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Gastroenterology, Mech-Sense, Aalborg University Hospital, 9000 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LONG COVID EXP CM</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant><Grant><GrantID>NNF21OC0067235</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">pain</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">single nucleotide polymorphism</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36233516</ArticleId><ArticleId IdType="pmc">PMC9570972</ArticleId><ArticleId IdType="doi">10.3390/jcm11195645</ArticleId><ArticleId IdType="pii">jcm11195645</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu J., Ji P., Pang J., Zhong Z., Li H., He C., Zhang J., Zhao C. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J. Med. Virol. 2020;92:1902&#x2013;1914. doi: 10.1002/jmv.25884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25884</ArticleId><ArticleId IdType="pmc">PMC7262119</ArticleId><ArticleId IdType="pubmed">32293716</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet. Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Visco V., Vitale C., Rispoli A., Izzo C., Virtuoso N., Ferruzzi G.J., Santopietro M., Melfi A., Rusciano M.R., Maglio A., et al. Post-COVID-19 syndrome: Involvement and interactions between respiratory, cardiovascular and nervous systems. J. Clin. Med. 2022;11:524. doi: 10.3390/jcm11030524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030524</ArticleId><ArticleId IdType="pmc">PMC8836767</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., Palacios-Ce&#xf1;a D., Arendt-Nielsen L. Time course prevalence of Post-COVID pain symptoms of musculoskeletal origin in patients who had survived to SARS-CoV-2 infection: A systematic review and meta-analysis. Pain. 2022;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulchandani R., Lyngdoh T., Kakkar A.K. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur. J. Clin. Investig. 2021;51:e13429. doi: 10.1111/eci.13429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13429</ArticleId><ArticleId IdType="pmc">PMC7646004</ArticleId><ArticleId IdType="pubmed">33058143</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes E.A., Haghbayan H. Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev. Med. Virol. 2020;30:1&#x2013;9. doi: 10.1002/rmv.2141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T., Narazaki M., Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold. Spring. Harbor. Perspect. Biol. 2014;6:a01629. doi: 10.1101/cshperspect.a016295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a016295</ArticleId><ArticleId IdType="pmc">PMC4176007</ArticleId><ArticleId IdType="pubmed">25190079</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro G. SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the &#x2018;culprit lesion&#x2019; of ARDS onset? What is there besides Tocilizumab? SGP130Fc. Cytokine X. 2020;2:100029. doi: 10.1016/j.cytox.2020.100029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytox.2020.100029</ArticleId><ArticleId IdType="pmc">PMC7224649</ArticleId><ArticleId IdType="pubmed">32421092</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong J., Dong H., Xia Q.S., Huang Z.Y., Wang D.K., Zhao Y., Liu W.H., Tu S.H., Zhang M.M., Wang Q., et al. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: A retrospective study. BMC Infect. Dis. 2020;20:963. doi: 10.1186/s12879-020-05681-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05681-5</ArticleId><ArticleId IdType="pmc">PMC7750784</ArticleId><ArticleId IdType="pubmed">33349241</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis E.J., Netea M.G., Rovina N., Akinosoglou K., Antoniadou A., Antonakos N., Damoraki G., Gkavogianni T., Adami M.E., Katsaounou P., et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell. Host. Microbe. 2020;27:992&#x2013;1000. doi: 10.1016/j.chom.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Zhang H., Dauphars D.J., He Y.W. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends. Immunol. 2021;42:3&#x2013;5. doi: 10.1016/j.it.2020.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.012</ArticleId><ArticleId IdType="pmc">PMC7605819</ArticleId><ArticleId IdType="pubmed">33214057</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamura A.P.D., Tavares da Silva M.R., H&#xfc;mmelgen A.L., Soeiro Pereira P.V., Falcai A., Grumach A.S., Goudouris E., Neto A.C., Prando C. Immunity and inflammatory biomarkers in COVID-19: A systematic review. Rev. Med. Virol. 2021;31:e2199. doi: 10.1002/rmv.2199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2199</ArticleId><ArticleId IdType="pubmed">34260778</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microbes. Infect. 2020;9:1123&#x2013;1130. doi: 10.1080/22221751.2020.1770129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770129</ArticleId><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends. Cell. Biol. 2001;11:372&#x2013;377. doi: 10.1016/S0962-8924(01)02064-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(01)02064-5</ArticleId><ArticleId IdType="pubmed">11514191</ArticleId></ArticleIdList></Reference><Reference><Citation>Everitt A.R., Clare S., Pertel T., John S.P., Wash R.S., Smith S.E., Chin C.R., Feeley E.M., Sims J.S., Adams D.J., et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012;484:519&#x2013;523. doi: 10.1038/nature10921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10921</ArticleId><ArticleId IdType="pmc">PMC3648786</ArticleId><ArticleId IdType="pubmed">22446628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakim L.M., Gupta N., Mintern J.D., Villadangos J.A. Enhanced survival of lung tissue-resident memory CD8&#x207a; T cells during infection with influenza virus due to selective expression of IFITM3. Nat. Immunol. 2013;14:238&#x2013;245. doi: 10.1038/ni.2525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2525</ArticleId><ArticleId IdType="pubmed">23354485</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltoum A.B.O. Mutations and polymorphisms in genes involved in the infections by COVID-19: A review. Gene. Rep. 2021;23:101062. doi: 10.1016/j.genrep.2021.101062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2021.101062</ArticleId><ArticleId IdType="pmc">PMC7906531</ArticleId><ArticleId IdType="pubmed">33655087</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Lin Y.X., Zha Y., Sun Y., Tian J., Yang Z., Lin S.W., Yu F., Chen Z.S., Kuang B.H., et al. A low-producing haplotype of interleukin-6 disrupting CTCF binding is protective against severe COVID-19. MBio. 2021;12:e0137221. doi: 10.1128/mBio.01372-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01372-21</ArticleId><ArticleId IdType="pmc">PMC8510538</ArticleId><ArticleId IdType="pubmed">34634929</ArticleId></ArticleIdList></Reference><Reference><Citation>Falahi S., Zamanian M.H., Feizollahi P., Rezaiemanesh A., Salari F., Mahmoudi Z., Gorgin Karaji A. Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population. Cytokine. 2022;154:155889. doi: 10.1016/j.cyto.2022.155889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.155889</ArticleId><ArticleId IdType="pmc">PMC9015956</ArticleId><ArticleId IdType="pubmed">35461173</ArticleId></ArticleIdList></Reference><Reference><Citation>Karcioglu Batur L., Hekim N. Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries. J. Med. Virol. 2021;93:5853&#x2013;5863. doi: 10.1002/jmv.27127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27127</ArticleId><ArticleId IdType="pmc">PMC8242628</ArticleId><ArticleId IdType="pubmed">34081354</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh A., Sultan A., Elashry M.A., Farag A., Mortada M.I., Ghannam M.A., Saed A.M., Ghoneem E. Association of TNF-&#x3b1; G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients. Immunol. Investig. 2022;51:546&#x2013;557. doi: 10.1080/08820139.2020.1851709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08820139.2020.1851709</ArticleId><ArticleId IdType="pmc">PMC7711738</ArticleId><ArticleId IdType="pubmed">33228423</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ara&#xfa;jo J.L.F., Menezes D., de Aguiar R.S., de Souza R.P. IFITM3, FURIN, ACE1, and TNF-&#x3b1; genetic association with COVID-19 outcomes: Systematic review and meta-analysis. Front. Genet. 2022;13:775246. doi: 10.3389/fgene.2022.775246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.775246</ArticleId><ArticleId IdType="pmc">PMC9010674</ArticleId><ArticleId IdType="pubmed">35432458</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wei L., He L., Sun J., Liu N. Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis. J. Infect. 2022;84:825&#x2013;833. doi: 10.1016/j.jinf.2022.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.04.029</ArticleId><ArticleId IdType="pmc">PMC9022375</ArticleId><ArticleId IdType="pubmed">35461906</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrot S., Cohen M., Barke A., Korwisi B., Rief W., Treede R.D., IASP Taskforce for the Classification of Chronic Pain The IASP classification of chronic pain for ICD-11: Chronic secondary musculoskeletal pain. Pain. 2019;160:77&#x2013;82. doi: 10.1097/j.pain.0000000000001389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001389</ArticleId><ArticleId IdType="pubmed">30586074</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Giordano R., D&#xed;az-Gil G., Gil-Crujera A., G&#xf3;mez-S&#xe1;nchez S.M., Ambite-Quesada S., Arendt-Nielsen L. Are pain polymorphisms associated with the risk and phenotype of post-COVID pain in previously hospitalized COVID-19 survivors? Genes. 2022;13:1336. doi: 10.3390/genes13081336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13081336</ArticleId><ArticleId IdType="pmc">PMC9394327</ArticleId><ArticleId IdType="pubmed">35893072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer T.G., Neblett R., Cohen H., Howard K.J., Choi Y.H., Williams M.J., Perez Y., Gatchel R.J. The development and psychometric validation of the central sensitization inventory. Pain. Pract. 2012;12:276&#x2013;285. doi: 10.1111/j.1533-2500.2011.00493.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1533-2500.2011.00493.x</ArticleId><ArticleId IdType="pmc">PMC3248986</ArticleId><ArticleId IdType="pubmed">21951710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M.I., Smith B.H., Torrance N., Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research. J. Pain. 2005;6:149&#x2013;158. doi: 10.1016/j.jpain.2004.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2004.11.007</ArticleId><ArticleId IdType="pubmed">15772908</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a Campayo J., Rodero B., Alda M., Sobradiel N., Montero J., Moreno S. Validation of the Spanish version of the Pain Catastrophizing Scale in fibromyalgia. Med. Clin. 2008;131:487&#x2013;492. doi: 10.1157/13127277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1157/13127277</ArticleId><ArticleId IdType="pubmed">19007576</ArticleId></ArticleIdList></Reference><Reference><Citation>Woby S.R., Roach N.K., Urmston M., Watson P.J. Psychometric properties of the TSK-11: A shortened version of the Tampa Scale for Kinesiophobia. Pain. 2005;117:137&#x2013;144. doi: 10.1016/j.pain.2005.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2005.05.029</ArticleId><ArticleId IdType="pubmed">16055269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a M., de-la-Llave-Rinc&#xf3;n A.I., Fuensalida-Novo S., Florencio L.L., Ambite-Quesada S., Ortega-Santiago R., Arias-Bur&#xed;a J.L., Liew B.X.W., et al. Psychometric properties of the Hospital Anxiety and Depression Scale (HADS) in previously hospitalized COVID-19 patients. Int. J. Environ. Res. Public Health. 2022;19:9273. doi: 10.3390/ijerph19159273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19159273</ArticleId><ArticleId IdType="pmc">PMC9367824</ArticleId><ArticleId IdType="pubmed">35954630</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry. Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja O., Silva Passadouro B., Mulvey M., Delis I., Astill S., Tan A.L., Sivan M. Clinical characteristics and mechanisms of musculoskeletal pain in long COVID. J. Pain Res. 2022;15:1729&#x2013;1748. doi: 10.2147/JPR.S365026.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S365026</ArticleId><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Batur E.B., Korez M.K., Gezer I.A., Levendoglu F., Ural O. Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. Int. J. Clin. Pract. 2021;75:e14135. doi: 10.1111/ijcp.14135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14135</ArticleId><ArticleId IdType="pmc">PMC8250333</ArticleId><ArticleId IdType="pubmed">33686741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bak&#x131;lan F., G&#xf6;kmen &#x130;.G., Ortanca B., U&#xe7;an A., Eker G&#xfc;ven&#xe7; &#x15e;., &#x15e;ahin Mutlu F., G&#xf6;kmen H.M., Ekim A. Musculoskeletal symptoms and related factors in postacute COVID-19 patients. Int. J. Clin. Pract. 2021;75:e14734. doi: 10.1111/ijcp.14734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14734</ArticleId><ArticleId IdType="pmc">PMC8420386</ArticleId><ArticleId IdType="pubmed">34387911</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Ryan-Murua P., de-la-Llave-Rinc&#xf3;n A.I., G&#xf3;mez-Mayordomo V., Arendt-Nielsen L., Torres-Macho J. Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivors. Pain. 2022 doi: 10.1097/j.pain.0000000000002608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002608</ArticleId><ArticleId IdType="pmc">PMC9560903</ArticleId><ArticleId IdType="pubmed">35121694</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C., et al. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamariz L., Bast E., Abad M., Klimas N., Caralis P., Palacio A. Post COVID-19 joint pain: Preliminary report of the relationship with antinuclear antibodies and inflammation. J. Med. Virol. 2022;94:3479&#x2013;3481. doi: 10.1002/jmv.27753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27753</ArticleId><ArticleId IdType="pmc">PMC9088578</ArticleId><ArticleId IdType="pubmed">35355291</ArticleId></ArticleIdList></Reference><Reference><Citation>Florencio L.L., Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Systemic inflammation and obesity as therapeutic targets. Lancet. Respir. Med. 2022;10:726&#x2013;727. doi: 10.1016/S2213-2600(22)00159-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00159-X</ArticleId><ArticleId IdType="pmc">PMC9034853</ArticleId><ArticleId IdType="pubmed">35472305</ArticleId></ArticleIdList></Reference><Reference><Citation>The PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. E Clin. Med. 2022;53:201624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>